PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
1-Year Return
21.39%
This Quarter Return
+28.08%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.67B
AUM Growth
-$424M
(-20%)
Cap. Flow
-$724M
Cap. Flow
% of AUM
-43.42%
Top 10 Holdings %
Top 10 Hldgs %
45.69%
Holding
79
New
7
Increased
16
Reduced
26
Closed
15
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$60.6M |
| 2 |
Universal Health Services
UHS
|
$17M |
| 3 |
Avantor
AVTR
|
$15.4M |
| 4 |
Stryker
SYK
|
$13.9M |
| 5 |
Boston Scientific
BSX
|
$13.8M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$59.7M |
| 2 |
Cardinal Health
CAH
|
$55.5M |
| 3 |
Cytokinetics
CYTK
|
$53.6M |
| 4 |
UnitedHealth
UNH
|
$50.9M |
| 5 |
Intuitive Surgical
ISRG
|
$49.8M |
Sector Composition
| 1 | Healthcare | 96.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
EyePoint Pharmaceuticals
EYPT
$819M
| $3.95M | 0.24% |
+170,871
| New | +$3.95M |
|
52
Sagimet Biosciences
SGMT
$236M
| $3.67M | 0.22% |
676,453
| – | – |
|
53
Oscar Health
OSCR
$4.75B
| $3.08M | 0.18% |
336,166
| – | – |
|
|
CMPS
54
Compass Pathways
CMPS
$489M
| $2.96M | 0.18% |
338,761
+285,890
| +541% | +$2.5M |
|
|
BLUE
55
DELISTED
bluebird bio
BLUE
| $2.82M | 0.17% |
102,133
-199,914
| -66% | -$5.52M |
|
56
Generation Bio
GBIO
$38.9M
| $2.68M | 0.16% |
162,249
-89,195
| -35% | -$1.47M |
|
57
Celcuity
CELC
$2.31B
| $2.29M | 0.14% |
156,997
-53,554
| -25% | -$780K |
|
|
TSBX
58
DELISTED
Turnstone Biologics
TSBX
| $1.61M | 0.1% |
633,313
-891,397
| -58% | -$2.27M |
|
59
Celldex Therapeutics
CLDX
$1.51B
| $1.39M | 0.08% |
+35,000
| New | +$1.39M |
|
60
Akero Therapeutics
AKRO
$3.52B
| – | – |
-214,298
| Closed | -$10.8M |
|
61
Alkermes
ALKS
$4.77B
| – | – |
-1,162,030
| Closed | -$32.5M |
|
62
Biogen
BIIB
$20.5B
| – | – |
-186,635
| Closed | -$48M |
|
63
BioMarin Pharmaceuticals
BMRN
$10.9B
| – | – |
-498,280
| Closed | -$44.1M |
|
|
64
Cardinal Health
CAH
$35.7B
| – | – |
-639,783
| Closed | -$55.5M |
|
65
DexCom
DXCM
$31.7B
| – | – |
-318,769
| Closed | -$29.7M |
|
66
Editas Medicine
EDIT
$227M
| – | – |
-82,281
| Closed | -$642K |
|
67
iRhythm Technologies
IRTC
$5.85B
| – | – |
-485,468
| Closed | -$45.8M |
|
68
Lantheus
LNTH
$3.66B
| – | – |
-372,761
| Closed | -$25.9M |
|
69
Arcus Biosciences
RCUS
$1.23B
| – | – |
-1,405,056
| Closed | -$25.2M |
|
70
Sarepta Therapeutics
SRPT
$1.93B
| – | – |
-250,967
| Closed | -$30.4M |
|
71
Viridian Therapeutics
VRDN
$1.52B
| – | – |
-360,830
| Closed | -$5.54M |
|
|
NARI
72
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
0
| – | – |
|
|
IMGN
73
DELISTED
Immunogen Inc
IMGN
| – | – |
-869,889
| Closed | -$13.8M |
|
|
PNT
74
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| – | – |
-1,613,516
| Closed | -$10.8M |
|
|
SGEN
75
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-281,617
| Closed | -$59.7M |
|